2breathe Technologies Ltd. and its founders are pioneers in the development of the digital therapeutic devices field, first in hypertension and now in sleeplessness. The original product, RESPeRATE® (www.resperate.com), is the world’s first FDA-cleared, non-drug hypertension treatment device now used by hundreds of thousands of patients is featured in the American Heart Association statement on non-pharmacological treatments. The new product, 2breathe™, adopts RESPeRATE guided-breathing technology for individuals who have difficulties falling asleep. 2breathe is not a medical device and is not intended to diagnose or treat medical conditions.
View Top Employees from 2breathe Technologies Ltd.| Website | http://www.resperate.com |
| Revenue | $43 million |
| Employees | 5 (3 on RocketReach) |
| Phone | (646) 652-5800 |
| Fax | (212) 967-5060 |
| Industry | Medical Devices, Medical Devices & Equipment, Manufacturing |
| Competitors | DentLight, Inc., Myotronics Inc, Pulmonx Corporation, SenoRx, Spiration, Inc. dba Olympus Respiratory America |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
Looking for a particular 2breathe Technologies Ltd. employee's phone or email?
2breathe Technologies Ltd. Questions
The 2breathe Technologies Ltd. annual revenue was $43 million in 2023.
3 people are employed at 2breathe Technologies Ltd..
The SIC codes for 2breathe Technologies Ltd. are [38, 384].
Top 2breathe Technologies Ltd. Employees
Related Companies
